Arnav is a physician-scientist at The Column Group with expertise in cancer biology, single-cell genomics, and machine learning. He is part of the founding team of Juri Biosciences at TCGLabs-Soleil.…
John is a leader in cancer research and molecular pathology, helping guide translational cancer research at Massachusetts General Hospital, where he also directed the Clinical Molecular Diagnostics Lab. He focuses…
Keith made seminal contributions to melanoma treatment by establishing the efficacy of BRAF, MEK, and combined BRAF/MEK inhibition in metastatic melanoma, with findings published in the New England Journal of Medicine as…
Liron’s research focuses on uncovering fundamental mechanisms of metabolic signaling in cancer and applying advanced biochemical approaches to identify new therapies. His lab has made significant contributions to understanding how…
Jeff brings over 22 years of experience in cancer research and drug development. Most recently, he served as Chief Scientific and Development Officer at Ikena Oncology, where he led research…
